Skip to content


  • Oral presentation
  • Open Access

Targeted exon capture and NGS to investigate an undefined myopathy reveal RYR1 variants

  • Kathryn Stowell1,
  • Elaine Langton2,
  • Neil Pollock3 and
  • Anja Schiemann1
BMC Anesthesiology201414(Suppl 1):A15

Published: 18 August 2014


Creatine KinaseCalcium ReleasePremature Stop CodonMalignant HyperthermiaMalignant Hyperthermia


The family under investigation consists of parents and two daughters, one being the proband. The mother and the proband have elongated facial features. The father and second daughter appear normal. The older daughter presented for elective tonsillectomy aged 8 years. She had severe masseter spasm after suxamethonium. The rest of the procedure was carried out under total intravenous anaesthesia. No blood gas analysis could be done, but a creatine kinase next day was significantly elevated (2934). This led to study of both parents. There was no family history of malignant hyperthermia but an undefined myopathy was suspected in mother and daughter. Both mother and father were diagnosed malignant hyperthermia (MH) susceptible by in vitro contracture test (IVCT). This prompted a DNA analysis for variants associated with MH.

Materials and methods

Standard histochemistry, biochemistry and electron microscopy were carried out on muscle tissue from the mother. DNA from all four family members was analysed by targeted exon capture and next generation sequencing using the Ion Torrent platform. B-lymphoblastoid cells were generated from all family members and assayed for abnormal calcium release.


The mother and both daughters carry a premature stop codon in ryanodine receptor subtype 1 (RYR1) as well an uncharacterized RYR1 variant inherited from the father. The mother also carries a second uncharacterized RYR1 variant, not inherited by either daughter. Muscle histology showed two cox-negative fibres suggestive of a mitochondrial disorder but not definitive. Calcium release assays using B-lymphoblastoid cells suggest a hypersensitive RyR1 channel in all four family members.


The RYR1 variants identified cannot be definitively associated with susceptibility to MH, although the functional assays in B-lymphoblastoid cells suggest a hypersensitive channel. It is possible that the undefined myopathy is associated with another gene and the MH susceptible result by IVCT is unrelated to this condition. Further analysis of the family is required for a definitive diagnosis.

Authors’ Affiliations

Institute of Fundamental Sciences, Massey University, Palmerston North, New Zealand
Department of Anesthesiology, Wellington Hospital, Wellington, New Zealand
Department of Anesthesiology, Palmerston North Hospital, Palmerston North, New Zealand


© Stowell et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.